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Vertebral marrow lesionsAbstract Background: Although the spine is the most common site of bone metastasis and the
third most common site for metastatic disease following the lung and the liver, benign vertebral
fracture due to osteopenia occurs in one third of cancer patients making it essential to determine
whether the cause of vertebral collapse is benign or malignant.
Objective: To detect and differentiate benign from malignant vertebral marrow lesions with the use
of Diffusion weighted MRI and chemical shift in order to optimize the protocol needed for the
accurate diagnosis.
Materials and methods: In our study, we interpreted and analyzed the imaging data of 30 patients
with suspected vertebral marrow lesion. They performed the routine MRI sequences of the spine
(T1, T2, STIR, T1 fat sat post-contrast enhancement) as well as the two non-routine sequences
(DWI & in/opposed phase). We used the biopsy results or results of clinical and radiologic follow-
up for at least 6 months, as the gold standard to classify the vertebral marrow inﬁltrative lesions as
benign or malignant.
Results: Statistical analysis of the collected results was performed using DWI with its quantitative
best cutoff ADC value being 0.67  103 mm2/s and chemical shift imaging with its quantitative
best cutoff SIR being 0.94 showed their diagnostic value in discrimination between benign and
malignant lesions with overall 94% sensitivity, 79% speciﬁcity, 87% accuracy for ADC value
and 94% sensitivity, 71% speciﬁcity, 83% accuracy for SIR.
Conclusion: The addition of the two evolving MRI sequences (DWI and CSI) to the routine MRI
protocol of cancer patients who examine the spine as part of their metastatic work-up promises to
be an effective implement for characterization of vertebral marrow lesions being benign versus
malignant.
 2016TheEgyptian Society ofRadiology andNuclearMedicine. Production and hosting byElsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
558 M.Y. Tadros, A.L. Louka1. Introduction
Vertebral marrow lesions in patients with known primary
malignancy are a common clinical problem, particularly in
elderly patients. In spite of osteoporosis being the commonest
cause at this age, the spine also is a common site of metastases,
with about 39% of all bone metastases occurring in the spine.
Such metastases may result in a pathologic fracture (1).
Differentiation of different vertebral marrow lesions
whether pathologic from benign ones, deﬁnitely affects clinical
staging, treatment strategy and prognosis in patients with
known malignancies. Although conventional magnetic reso-
nance (MR) imaging represents a sensitive method in the
assessment of bone marrow, sometimes it lacks speciﬁcity (2).
New techniques were tried for distinguishing between
malignant and benign bone marrow with varying success.
These included chemical shift imaging and diffusion-weighted
MR imaging allowing for increased conspicuity of lesions. In
equivocal ﬁndings of bone marrow lesions gadolinium
enhanced study may be done. Although this increases the
length and expense of the MR examination, it is not clear
whether it improves diagnosis (2).
The aim of our study was to evaluate the diagnostic accu-
racy of in-phase/opposed-phase quantitative chemical shift
imaging of the spine and to determine the cutoff value between
benign and malignant vertebral marrow lesions using diffusion
weighted MRI imaging with quantitative ADC value, espe-
cially in patients with known primary malignant neoplasms.
2. Materials and methods
2.1. Subjects
This study included 30 patients, who were examined between
June 2013 and January 2015, at MRI Unit of a University
Hospital. Most of them were referred with a history of known
primary malignancy and clinically suspected vertebral metas-
tases. The rest of these patients were referred with back pain.
Inclusion criteria were as follows: no age or sex predilection,
any patient with primary neoplasm and suspected vertebral
marrow lesion. Exclusion criteria were as follows: Patients
who had not underwent a histopathological examination or
6 month follow-up (gold standard) and Patients known to
have contraindications for MRI e.g. an implanted magnetic
device, pacemakers and severe renal insufﬁciency with
glomerular ﬁltration rate <30 ml/min and serum creatinine
>2.0 mg/dl as regards contrast injection. Our study popula-
tion was presented to us either with back pain and/or with a
neurological deﬁcit after no or minimal trauma (e.g., falling
from a standing height).
Those with known primary tumors were 23 patients of the
30 s: Lymphoma (n= 1), carcinoma of breast (n= 5), leuke-
mia (n= 1), sarcoma (n= 5), carcinoma of prostate (n= 1),
cervical chordoma (n= 1), thyroid carcinoma (n= 1), renal
cell carcinoma (n= 1), hepatocellular carcinoma (n= 3) and
bronchogenic carcinoma (n= 4).
All cases underwent conventional MRI (T1, T2, and STIR),
DWI and chemical shift sequences. Twenty-four out of 30
patients received intravenously 0.1 mmol/kg of Gadolinium-
DTPA as part of the routine protocol of oncology patient at
our MRI unit. Two out of 30 patients did not receive intra-venous contrast because of severe renal insufﬁciency. The rest
four patients refused to receive contrast.
2.2. Acquisition and processing of MRI
MR imaging of the spine was performed to 30 patients and it
included examination of the cervical spine (n= 2), dorsal
spine (n= 4) and lumbosacral region (n= 18); 1 patient had
undergone cervicodorsal study, and 5 patients dorsolumbar
study.
All examinations were performed on a 1.5 MR scanner
(Achieva; Philips Medical Systems, Bothell, WA, USA) using
a spine radio-frequency surface array coil.
Patients with known primary malignancy received gadolin-
ium as part of the routine protocol of cancer patient at our
MRI unit which consists of the following routine sequences:
Unenhanced sagittal and axial T1-weighted fast spin-echo
sequence, a sagittal and axial T2-weighted fast spin-echo
sequence, a sagittal T2-weighted STIR sequence and a contrast
enhanced sagittal and axial T1-weighted sequence with fat
suppression.
In this study 2 non-routine sequences of sagittal diffusion-
weighted imaging and chemical shift (in/opposed phase)
sequences were added to all patients.
2.2.1. Scanning protocol
Sagittal T1-weighted turbo spin echo images were acquired
(TR/TE, 424/9; number of slices, 12; slice thickness, 4 mm;
gap, 0.4 mm; ﬂip angle, 80_; FOV, 300 mm2). The total imag-
ing time was 1:54 min. Axial T1-weighted turbo spin echo
images were done (TR/ TE, 575/10; number of slices, 25; slice
thickness, 5 mm; gap, 0.5 mm; ﬂip angle, 80_; FOV, 200 mm2).
The total scan duration was 1:46 min.
Sagittal T2-weighted turbo spin echo images were per-
formed (TR/TE, 2578/100; number of slices, 12; slice thickness,
4 mm; gap, 0.4 mm; ﬂip angle, 90_; FOV, 300 mm2). The total
imaging time was 1:51 min.
Axial T2-weighted turbo spin echo images were performed
(TR/TE, 3000/100; number of slices, 25; slice thickness, 5 mm;
gap, 0.5 mm; ﬂip angle, 90_; FOV, 200 mm2). The total imag-
ing time was 1:06 min.
Sagittal T2-weighted STIR images were acquired (TR/TE,
3761/80; number of slices, 12; slice thickness, 3.8 mm; gap,
1.2 mm; ﬂip angle, 90_; FOV, 300 mm2). The total imaging
duration was 2:08 min.
In addition to the routine sequences, sagittal in-phase (TR/
TE, 10/4.6; number of slices, 12; slice thickness, 4 mm; gap,
1 mm; ﬂip angle, 15_; FOV, 300 mm2 and the total imaging
duration was 14.1 s) and opposed-phase gradient recalled-
echo sequences (TR/TE, 10/2. 3; number of slices, 12; slice
thickness, 4 mm; gap, 1 mm; ﬂip angle, 15_; FOV, 300 mm2
and the total imaging duration was 13.6 s) were acquired.
DWI was performed with free breathing and inversion
recovery single-shot spin-echo echo-planar sequences (TR/
TE, 9000/68; number of slices, 12; slice thickness, 5 mm; gap,
0 mm; ﬂip angle, 90_; FOV, 300 mm2). We applied 3
diffusion-sensitizing gradients with b-values of 0, 50 and
800 s/mm2. The total imaging time was 6:09 min.
After manual intravenous administration of 0.1 mmol/kg of
gadolinium-DTPA, axial and sagittal T1-weighted fat sup-
pressed sequences with the following parameters were applied:
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gap, 0 mm; ﬂip angle, 90; FOV, 300 mm2. The total scan
duration was 1:43 min for sagittal images and 2:26 min for
axial scan.
The routine scan time was 7 min and 36 s, the DWI scan
time was 6 min and 9 s and the chemical shift scan time was
27.7 s. So, DWI and CSI added to the routine scan time
6 min and 36.7 s.
2.2.2. Image analysis
All images were loaded to a workstation (HPZR 24 W; Philips
Medical Systems). Bone marrow evaluation and image
interpretation were performed by specialized radiologists.
They interpreted both routine MRI sequences (T1-weighted,
T2-weighted, STIR and gadolinium-enhanced T1-weighted
fat-suppressed sequence) and non-routine sequences (DWI
and in/opposed phase imaging).
2.2.3. Qualitative analysis
Bone marrow signal intensity was qualitatively analyzed by
visually comparing its signal intensity with the signal intensity
of the non-degenerated intervertebral disk, subcutaneous fat
and muscle tissue depicted on T1-weighted images. For MRI
interpretation, we used previously established diagnostic
criteria for vertebral bone marrow evaluation to include the
following: Malignant marrow lesions, whether multifocal or
diffuse, were deﬁned as those being isointense or hypo intense
to muscle or intervertebral disk on T1-weighted images with
corresponding hyper intensity on T2-weighted or STIR images
and hyper intense on the DWI with a high b-value (b-value =
800), lack normal signal dropout on out-of-phase compared
with in-phase images and show avid post-contrast
enhancement.
On the other hand bone marrow lesion with signal intensity
on T1-weighted images higher than disk and muscle, with no
abnormal signal changes on STIR images, with a signal drop-
out on out-of-phase imaging compared with in-phase images,
not hyper intense on high b value DWI and did not show
post-contrast enhancement was classiﬁed as benign.
2.2.4. Quantitative analysis
Image post-processing was performed using a workstation (HP
ZR 24 W; Philips Medical Systems). We quantitatively evalu-
ated the bone marrow signal intensity by performing measure-
ments in regions of interest (ROI). Hyper intense lesions on the
DWI with a high b-value (b 800) which correspond to signal
intensity changes on the T1-weighted spin-echo MR images
were identiﬁed and the regions of interest were manually
drawn. The ROI was lesion-size-dependent in localized discrete
lesions, but in diffuse vertebral marrow lesions it was drawn as
large as possible placed in the anterocentral aspect of vertebral
body to avoid vertebral end plate degenerative changes and
basivertebral vein plexus. These regions of interest varied
between 5 and 15 mm in diameter. In each patient at least 3
ROIs were applied. The ROIs were copied into the computer
memory and pasted onto registered ADC maps. ADC values
were automatically calculated using the software provided by
the MR scanner manufacturer (Diffusion Calculation: Philips
Medical Systems) and the ADC quantitative parameter was
expressed in square millimeters per second as mean ± SD.The average ADC value of the three regions of interest of each
patient was calculated and recorded.
As regards chemical shift imaging areas within the vertebral
bodies that were of abnormal signal intensity on T1, T2
weighted and STIR sequences were identiﬁed on the in-phase
and out-of-phase sequences. A region of interest (ROI) was
applied to contain the abnormal area on the in-phase images
and copied into the computer memory to be pasted onto the
out-of-phase images. In case of multiple affected vertebrae
only one representative lesion was used per patient.
In each affected vertebra 3 ROIs were applied to measure
the signal intensity that was expressed as mean ± standard
deviation (SD). The average signal intensity value of the three
regions of interest was calculated and recorded for both in-
phase and out-phase sequences.
The signal intensity ratio (SIR) of the marrow mean signal
intensity on the opposed-phase to the mean signal intensity on
the in-phase images was calculated and recorded for each
affected vertebra (benign and malignant) to quantitatively esti-
mate the change that occurred in the signal intensity of abnor-
mal marrow, with out-of-phase image.
The ﬁnal diagnosis that was made on the basis of biopsy
results or results of clinical and radiologic follow-+up for at
least 6 months later, was used as the ‘‘gold standard’’ to clas-
sify the vertebral marrow inﬁltrative lesions as benign or
malignant.
The malignant nature of the lesion was established by pro-
gressive deterioration of an affected vertebra or newly devel-
oped other spinal metastases at follow-up MR imaging,
computed tomography, bone scintigraphy, or plain radiogra-
phy. When the ﬁndings of the follow-up studies did not pro-
gress or if the abnormal signal intensity of the affected
vertebra was resolved and reconstitution of normal marrow
signal was monitored, the lesion was considered to be benign.
2.2.5. Statistical analysis
Data were analyzed using MedCalc version 14 (MedCalc
Software bib, Ostend, Belgium) and the DAG Stat spreadsheet
(Mackinnon, 2000).
Normally distributed numerical variables were presented as
mean (SD). Categorical variables were presented as number
(%) and inter-group differences were compared using the Pear-
son chi-squared test or Fisher’s exact test, when appropriate.
Skewed numerical variables were presented as median
(interquartile range) and between-group comparisons were
done using the Mann–Whitney U test.
Receiver-operating characteristic (ROC) curve analysis was
used to examine the value of the ADC or the SIR for discrim-
ination between benign and malignant lesions. The DeLong
method was used to compare the area under various ROC
curves (AUC).
The diagnostic value of a restricted DWI pattern or no sig-
nal drop by CSI was examined by construction of two-by-two
contingency tables with the ultimate classiﬁcation of lesions
into benign or malignant by biopsy or 6-month follow-up
regarded as the gold standard for lesion classiﬁcation. The fol-
lowing diagnostic indices were then calculated: sensitivity,
speciﬁcity, positive predictive value, negative predictive value,
positive likelihood ratio, negative likelihood ratio, correct clas-
siﬁcation rate, and misclassiﬁcation rate.
Table 1 Primary diagnosis.
Primary diagnosis Frequency Percent
AML 1 3.3
Breast carcinoma 1 3.3
Bronchogenic carcinoma 2 6.7
Carcinoma of the prostate 1 3.3
Cervical chordoma 1 3.3
Hemangioma with modic changes 1 3.3
HCC 1 3.3
Lymphoma of the spleen 1 3.3
Metastatic breast carcinoma 4 13.3
Metastatic HCC 2 6.7
Metastatic NSCLC 1 3.3
Metastatic thyroid carcinoma 1 3.3
Multicentric neurosarcoma 1 3.3
Neuroﬁbromatosis 1 3.3
Osteoporosis 2 6.7
Osteosarcoma of the leg 1 3.3
Pott’s disease 2 6.7
Pubic bone sarcoma 1 3.3
RCC 1 3.3
Sarcoma of the back 2 6.7
SCLC 1 3.3
Spondylodiscitis 1 3.3
560 M.Y. Tadros, A.L. LoukaComparison of the sensitivities of restricted DWI pattern or
no signal drop by CSI was examined by construction of a two-
by-two contingency table for malignant lesions (positive
group). Discordance between the two methods was then tested
using the McNemar test. For comparison of the speciﬁcities of
the two methods, a similar contingency table was constructed
for benign lesions (negative group) and the McNemar test was
applied to examine discordance between the two methods.
Inter-method agreement was assessed by calculation of the
Cohen kappa statistic (j) and the prevalence-adjusted and
bias-adjusted kappa (PABAK) coefﬁcient.Fig. 1 Pie chart showing the primary3. Results
The studied population included 30 patients, 18 males (60%)
and 12 females (40%). The mean age was 54 ± 13 years rang-
ing from 25 to 80 years. Those with known primary malignant
lesion were 23 patients (76.7%), while 7 patients (23.3%) had
no known primary malignancy (Table 1) and (Fig. 1).
The gold standard for lesion classiﬁcation was either by
biopsy or by 6 month follow-up. 16 (53.3%) patients were
proved to be malignant and the other 14 (46.7%) were proved
to be benign, in which 22 (73.3%) patients out of 30 showed
restricted diffusion and 8 (26.7%) showed facilitated diffusion
with median ADC value 0.6 (0.4–1.3)  103 mm2/s. On the
other hand 19 (63.3%) patients out of the 30 showed no signal
drop on CSI and 11 (36.7%) showed signal drop with median
SIR 1.13 (0.74–1.3).
15 (93.8%) out of the 16 patients proved to be malignant by
the gold standard classiﬁcation showed restricted diffusion
with median ADC value 0.51 (0.37–0.60). Also, 15 (93.8%)
of them showed no signal drop by CSI with median SIR
1.22 (1.10–1.31). The P-value is statistically signiﬁcant
(p< 0.05).
On the other hand 7 (50%) out of the 14 patients proved to
be benign by the gold standard showed facilitated diffusion
with median ADC value 1.30 (1.20–1.40) and 10 (71.4%)
showed signal drop by CSI with median SIR 0.71
(0.59–1.30). The P-value is statistically signiﬁcant (Table 2)
(p< 0.05) (see Figs. 2–5).
The following table shows the diagnostic value of a
restricted pattern by DWI for the discrimination between
benign and malignant lesions with overall sensitivity of 0.94
(95% CI, 0.3–0.1), speciﬁcity of 0.50 (95% CI, 0.23–0.77)
and accuracy of 0.73 (95% CI, 0.54–0.88) (Table 3).
On the other hand the following table shows the diagnostic
value of no signal drop by CSI for the discrimination between
benign and malignant lesions with overall sensitivity of 0.94
(95% CI, 0.70–1.0), speciﬁcity of 0.71 (95% CI, 0.42–0.92)
and accuracy of 0.83 (95% CI, 0.65–0.94) (Table 4).diagnosis of the study population.
Fig. 3 Box plot showing the ADC value associated with benign
or malignant lesions. Box represents the range between the 1st and
3rd quartiles (interquartile range). Line inside the box represents
the median (2nd quartile). Error bars represent the minimum and
maximum values excluding outliers (rounded markers) and
extreme values (squared markers).
Table 2 Comparison of the radiologic characteristics of benign and malignant lesions.
Variable Benign (n= 14) Malignant (n= 16) p-value
DWI 0.012a
Facilitated 7 (50%) 1 (6.3%)
Restricted 7 (50%) 15 (93.8%)
ADC (103 mm3/s) 1.30 (1.20–1.40) 0.51 (0.37–0.60) 0.003b
CSI <0.001c
Signal drop 10 (71.4%) 1 (6.3%)
No signal drop 4 (28.6%) 15 (93.8%)
SIR 0.71 (0.59–1.30) 1.22 (1.10–1.31) 0.021b
Data are presented as number (%) or median (interquartile range).
a Fisher’s exact test.
b Mann–Whitney U test.
c Pearson chi-squared test.
Fig. 2 Prevalence of a facilitated or restricted DWI pattern in
association with benign or malignant lesions.
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CSI for the discrimination between benign and malignant
lesions (Table 5) (0.47 Cohen’s Kappa and 0.53 prevalence
and bias adjusted kappa).
14 patients out of the 16 proved to be malignant by the gold
standard showed concordance results i.e. restricted diffusion
on DWI with no Signal drop by CSI, while 6 patients out of
the 14 proved to benign by the gold standard showed concor-
dance results i.e. facilitated diffusion on DWI and signal drop
on CSI (Table 6).
Also, the results according to ROC curve for the discrimi-
nation between benign and malignant lesions (Table 7) using
the ADC value showed that the best cutoff criterion is ADC
of 60.67 (J-index, 0.72) with area under the ROC curve
(AUC) 0.82, and this means that 60.67 indicates malignant
result while >0.67 was deﬁned as benign results with a sensi-tivity of 94%, speciﬁcity of 79% and accuracy of 87% (see
Figs. 6–8).
While the ROC curve for the discrimination between
benign and malignant lesions (Table 8) using the SIR showed
that the best cutoff criterion is SIR of >0.94 (J-index, 0.65)
with area under the ROC curve (AUC) 0.75, this means that
>0.94 indicates malignant result while <0.94 was deﬁned as
benign results with a sensitivity of 94%, speciﬁcity of 71%
and accuracy of 83%.
The following table and ﬁgure show that the difference
between the AUC of the ROC for the discrimination between
benign and malignant lesions using the ADC value or the SIR
is of p-value 0.662 which is statistically non-signiﬁcant
(Table 9).
The results revealed that 13 patients out of the 16 proved to
be malignant by the gold standard showed ADC value 60.67
& SIR >0.94 i.e. concordance results. And 7 patients out of
14 patients proved to be benign showed ADC value >0.67
& SIR <0.94 i.e. concordance results (Table 10).
Fig. 4 Prevalence of signal drop or no signal drop by CSI in
association with benign or malignant lesions.
Fig. 5 Box plot showing the SIR associated with benign or
malignant lesions. Box represents the range between the 1st and
3rd quartiles (interquartile range). Line inside the box represents
the median (2nd quartile). Error bars represent the minimum and
maximum values.
Table 3 Diagnostic value of a restricted pattern by DWI for
the discrimination between benign and malignant lesions.
Ultimate diagnosis DWI
Restricted Non-
restricted
Total
Malignant 15 1 16
Benign 7 7 14
Total 22 8 30
Diagnostic index Estimate Lower
95% CI
Upper
95% CI
Sensitivity 0.94 0.70 1.00
Speciﬁcity 0.50 0.23 0.77
Predictive value of positive
test
0.68 0.45 0.86
Predictive value of negative
test
0.88 0.47 1.00
Likelihood ratio of positive
test
1.88 1.09 3.21
Likelihood ratio of
negative test
0.13 0.02 0.90
Eﬃciency (Correct
classiﬁcation rate)
0.73 0.54 0.88
Misclassiﬁcation rate 0.27 0.12 0.27
Table 4 Diagnostic value of no signal drop by CSI for the
discrimination between benign and malignant lesions.
Ultimate diagnosis CSI
No signal
drop
Signal
drop
Total
Malignant 15 1 16
Benign 4 10 14
Total 19 11 30
Diagnostic index Estimate Lower
95% CI
Upper
95% CI
Sensitivity 0.94 0.70 1.00
Speciﬁcity 0.71 0.42 0.92
Predictive value of positive
test
0.79 0.54 0.94
Predictive value of
negative test
0.91 0.59 1.00
Likelihood ratio of
positive test
3.28 1.42 7.58
Likelihood ratio of
negative test
0.09 0.01 0.60
Eﬃciency (Correct
classiﬁcation rate)
0.83 0.65 0.94
Misclassiﬁcation rate 0.17 0.06 0.24
562 M.Y. Tadros, A.L. LoukaThe results showed moderate agreement between an ADC
value 60.67 and a SIR >0.94 for the discrimination between
benign and malignant lesions (0.39 Cohen’s Kappa and 0.40
prevalence and bias adjusted kappa) (Table 11).
4. Discussion
MR imaging using conventional T1 WI and T2 WI had proven
to be helpful in differentiating between benign and malignant
causes of vertebral collapse but conﬁdent diagnosis is not
always possible. When assessing contrast enhanced MRI,benign vertebral fractures may also enhance after intravenous
administration of contrast media due to a breach in blood tis-
sue. Dynamic contrast enhancement has been evaluated in the
characterization of lesions in the brain, liver, breast, pelvis,
etc., but this has not been evaluated in the spine (3).
An often encountered diagnostic dilemma in the MRI
interpretation is the difﬁculty in differentiating diffuse marrow
inﬁltrative lesions from the highly variable appearance of
normal hyper cellular hematopoietic red marrow (4).
Table 5 Agreement between DWI and CSI for the discrim-
ination between benign and malignant lesions.
CSI DWI
Restricted
(positive)
Non-restricted
(negative)
Total
No signal drop
(positive)
17 2 19
Signal drop
(negative)
5 6 11
Total 22 8 30
Cohen kappa (j) 0.47
95% CI for j 0.14–0.80
PABAK 0.53
PABAK, Prevalence and bias adjusted kappa.
Table 6 Comparison of the diagnostic value of a restricted
pattern by DWI and that of no signal drop by CSI.
CSI DWI
Non-restricted Restricted Total P valuea
Sensitivity comparison (Malignant group, n = 16)
Signal drop 0 1 1 1.000
No signal drop 1 14 16
Total 1 15 16
Specificity comparison (Benign group, n = 14)
Signal drop 6 4 10 0.375
No signal drop 1 3 4
Total 7 7 14
Data are presented as numbers of lesion.
a McNemar test.
Table 7 Receiver-operating characteristic (ROC) curve for
the discrimination between benign and malignant lesions using
the ADC value.
ROC curve index ADC
Area under the ROC curve (AUC) 0.82
95% CI for the AUC 0.64–1.00
p-value (AUC0 = 0.5) 0.001
Youden (J) index 0.72
Associated (best cutoﬀ) criterion (103 mm3/s) 60.67
Sensitivity (%) 93.75
95% CI for sensitivity 69.8–99.8
Speciﬁcity (%) 78.57
95% CI for speciﬁcity 49.2–95.3
Positive likelihood ratio (+LR) 4.37
95% CI for +LR 1.6–12.0
Negative likelihood ratio (LR) 0.08
95% CI for LR 0.01–0.5
Positive predictive value (+PV,%) 83.30
95% CI for +PV 58.6–96.4
Negative predictive value (PV,%) 91.70
95% CI for PV 61.5–99.8
Overall accuracy 86.69%
Fig. 6 Receiver-operating characteristic (ROC) curve for the
discrimination between benign and malignant lesions using the
ADC value.
Fig. 7 Receiver-operating characteristic (ROC) curve for the
discrimination between benign and malignant lesions using the
SIR.
Discrimination between benign and malignant in vertebral marrow lesions 563In a study done by Zhao et al. (5) who found that
T1-weighted MRI accurately depicted and characterized the
malignant multifocal metastatic deposits as well as focal anddiffuse red marrow that exhibited signal intensity higher than
adjacent muscle, but in our study 2 patients had profound
red marrow reconversion (Fig. 9) and 6 patients had advanced
osteoporosis (Fig. 10); it was difﬁcult to detect malignancy
based on T1-weighted image alone. This came in agreement
with Zidan and Elgahzaly (6).
Grifﬁth et al. (7) reported that on T1-weighted images,
osteoporosis can have a heterogeneous appearance because
of decreased cellular marrow components and increased fat
content. Also, hematopoietic marrow hyperplasia, diffuse
Fig. 8 Comparison of the receiver-operating characteristic
(ROC) curves for the discrimination between benign and malig-
nant lesions using the ADC value or the SIR.
Table 8 Receiver-operating characteristic (ROC) curve for
the discrimination between benign and malignant lesions using
the SIR.
ROC curve index SIR
Area under the ROC curve (AUC) 0.75
95% CI for the AUC 0.53–0.97
p-value (AUC0 = 0.5) 0.025
Youden (J) index 0.65
Associated (best cutoﬀ) criterion >0.94
Sensitivity (%) 93.75
95% CI for sensitivity 69.8–99.8
Speciﬁcity (%) 71.43
95% CI for speciﬁcity 41.9–91.6
Positive likelihood ratio (+LR) 3.28
95% CI for +LR 1.4–7.6
Negative likelihood ratio (LR) 0.09
95% CI for LR 0.01–0.6
Positive predictive value (+PV,%) 78.90
95% CI for +PV 54.4–93.9
Negative predictive value (PV,%) 90.90
95% CI for PV 58.7–99.8
Overall accuracy 83.35%
Table 10 Comparison of the diagnostic value of an ADC
value 6 0.67 and that of an SIR > 0.94.
SIR ADC
>0.67 60.67 Total P valuea
Sensitivity comparison (Malignant group, n = 16)
60.94 1 0 1 0.500
>0.94 2 13 15
Total 3 13 16
Specificity comparison (Benign group, n = 14)
60.94 7 3 10 1.000
>0.94 4 0 4
Total 11 3 14
Data are presented as numbers of lesion.
a McNemar test.
Table 11 Agreement between an ADC value 6 0.67 and an
SIR > 0.94 for the discrimination between benign and malig-
nant lesions.
SIR ADC
ADC 6 0.67
(positive)
ADC> 0.67
(negative)
Total
SIR > 0.94 (positive) 13 6 19
SIR 6 0.94 (negative) 3 8 11
Total 16 14 30
Cohen kappa (j) 0.39
95% CI for j 0.06–0.71
PABAK 0.40
PABAK, Prevalence and bias adjusted kappa.
564 M.Y. Tadros, A.L. Loukainﬂammatory/infective marrow edema and diffuse malignant
marrow inﬁltration showed diffuse high signal intensity on
STIR sequence. Routine MRI sequences were not speciﬁc forTable 9 Comparison of the receiver-operating characteristic (ROC
lesions using the ADC value or the SIR.
Source of ROC AUC 95% CI for AUC
ADC 0.82 0.64–1.00
SIR 0.75 0.53–0.97
AUC, area under the ROC curve; DAUC, difference between AUCs.
a DeLong method.the characterization of inﬁltrative marrow lesions as 8 out of
30 cases in our study were misinterpreted. This came in agree-
ment with Beltran and Shankman (8), Zhao et al. (5) and
Mubarak and Akhtar (3) who conﬁrmed the non-speciﬁcity
of routine sequences.
Schmid et al. (9) concluded that addition of T1-weighted
contrast-enhanced MR imaging does not alter the diagnosis
of bone marrow abnormalities, and for most cases, they rec-
ommend performing only the STIR sequence. Accordingly,
in our study we applied the two newly developed non-
contrast-based DWI and opposed phase chemical shift MR
techniques (non-routine sequences) on all cases.
Over the last decade, DWI MR imaging of the vertebral
body has proved its value and has been successfully
implemented for the differentiation of benign and malignant) curves for the discrimination between benign and malignant
DAUC 95% CI for DAUC p-valuea
0.07 0.26 to 0.40 0.662
Fig. 9 A 38-year-old male, presented with back mass proved to be back muscle sarcoma (a) Sagittal T1-weighted spin echo image shows
diffuse low signal intensity of lumbosacral vertebrae but still higher than adjacent muscle and isointense to non-degenerated intervertebral
disk. (b) Sagittal T2-weighted spin-echo image shows intermediate signal intensity of lumbosacral vertebrae. (c) DW image shows diffuse
hyperintense signal suggesting diffuse marrow inﬁltration. (d) ADC map shows average apparent diffusion coefﬁcient (ADC) value of
0.402  103 mm2/s. (e) In-phase and (f) out-of-phase gradient-echo MR images show normal signal dropout of vertebral marrow on out-
of-phase image compared with in-phase with calculated mean SIR = 0.78 conﬁrmed the benign nature of yellow to red marrow
reconversion. (g) Sagittal contrast-enhanced T1-weighted fat-suppressed MR image shows mild bone marrow enhancement. MR
diagnosis, diffuse yellow to red marrow reconversion. 6 month follow-up conﬁrmed the diagnosis of benign nature of yellow to red
marrow reconversion.
Discrimination between benign and malignant in vertebral marrow lesions 565fracture edema (due to tumor inﬁltration). DWI MRI provides
unique tissue characterization that is complementary to that
provided by conventional MR imaging and is sensitive to
microstructural changes. The reduced mobility of water in
pathologic fracture is the result of tumor cell accumulation
and subsequent reduction in the interstitial spaces that results
in high signal intensity compared with normal bone marrow.
On the other hand, the increased mobility of water attributed
to an increase in the interstitial space in relation to edema or
hemorrhage in benign fractures results in low signal intensity
in benign osteoporotic and traumatic fractures (3).
In our study we found that visual assessment of high-signal
intensity on high b-value (800) was not speciﬁc for malignancy
because inﬂammation and hyperactive hematopoietic marrow
can result in a similar diffusion restriction, and this came in
agreement with Koh et al. (10) and Ballon et al. (11). On the
other hand the quantitative assessment by measuring the
ADC value was able to distinguish benign from malignant
high signal intensity on DWI (Figs. 11 and 9). This was in
agreement with Zidan and Elghazaly (6) and Padhani et al.
(12) who highlighted the necessity of correlating high b-value
DW images with corresponding ADC values to prevent misin-
terpretation due to T2 shine-through. Our observations were
supported by Hillengass et al. (13) who showed that normal
yellow marrow had the lowest ADC value and the inﬁltrated
neoplastic marrow as well as hyper cellular red marrow had
higher ADC value (Fig. 9), with the infective/inﬂammatory
bone marrow lesion had the highest ADC value (Fig. 11).
Thus, it was concluded that signal intensity and ADC value
difference between yellow marrow and malignant marrow were
not overlapping, but the signal intensity difference between
malignant and inﬂammatory/infective lesion was overlapping
although the ADC value difference between the two entitieswas statistically signiﬁcant with p value < 0.05. This came in
agreement with Padhani et al. (12) and Zidan and Elghazaly
(6).
The diagnostic problem of narrow signal intensity differ-
ence between hypercellular red marrow and malignant inﬁltra-
tion was almost solved by the addition of in/out of- phase
chemical shift sequence to the MRI protocol.
Using ROC analysis, we identiﬁed an ADC cutoff value of
0.67 between benign and malignant vertebral marrow lesions,
which is lower than that reported by Wonglaksonapimon
et al. (14), namely 0.89, with sensitivity, speciﬁcity and accu-
racy were 86%, 91% and 90% respectively. In our study an
ADC cutoff value of 0.67 resulted in 94% sensitivity, 79%
speciﬁcity and 87% accuracy in the discrimination between
benign and malignant vertebral marrow lesions. These results
were in concordance with Sung et al. (15) who reported
100% sensitivity and 97% speciﬁcity.
Chemical shift imaging takes advantage of the small differ-
ences in precession frequency between fat and water protons to
determine the presence of microscopic fat and water within the
same imaging voxel. If a given voxel contains both fat and
water, drop of signal on out-of-phase images will be noted
(16).
On the other hand, lesions composed of virtually 100% fat
will not show a drop of signal on out-of-phase sequence, and
this was in concordance with our ﬁndings where some heman-
gioma, fat island, Modic type 2 vertebral endplate marrow
changes and radiotherapy induced profound fatty arrow did
not exhibit signal dropout (Fig. 12). Red marrow shows normal
signal dropout on out-of-phase images because of the presence
of both fat and water cells, but most neoplasms completely
replace or displace fat in the marrow space; thus, the neoplastic
area will lack normal signal dropout on out-of-phase images
Fig. 10 A 48-year-old female, with cancer thyroid, presented with back pain (a) Sagittal precontrast T1-weighted spin-echo image and
(b) sagittal T2-weighted spin-echo image as well as (c) Sagittal STIR show diffuse heterogenous signal intensity of lumbosacral vertebrae
suspicious of bone marrow inﬁltration or osteoporotic changes with variable degrees of compressed codﬁsh vertebral bodies at L5,4,2 and
D 11 levels (arrow). (d) DW image shows signiﬁcantly low marrow signal intensity with (e) average apparent diffusion coefﬁcient (ADC)
value of 0.142  103 mm2/s. (f) In-phase and (g) out-of-phase gradient-echo MR images show normal signal dropout of vertebral marrow
on out of-phase image compared with in-phase (d) with calculated mean SIR = 0.58. MR diagnosis, osteoporosis. 6 month follow-up
conﬁrmed no bone marrow metastatic inﬁltration and no progression.
566 M.Y. Tadros, A.L. Louka(16). And this was consistent with our ﬁndings and in
agreement with Zidan et al. (17).
Roberts et al. (18) suggested out-of-phase sequence to best
assess for marrow replacement by tumor. In our study the 2
cases with hypercellular red marrow showed a drop in signal
intensity on out-of-phase images, but no drop in signal inten-
sity was noted in malignant marrow lesions, and these results
were concordant with Moulopoulos et al. (19).
In our cases the addition of chemical shift sequence
improved the MRI diagnostic performance in discriminating
between benign and malignant marrow lesions.
We totally agreed with Zajack et al. (2) who noted that we
should not depend on visual conspicuity, as in our study we
found that the inﬂammatory/infective lesions showed no signal
drop in out of phase as regards visual assessment while quan-
titatively they were in concordance with benign lesions.
We expressed the ﬁndings of our results in the form of a
ratio, which compared the signal intensity in the abnormal
bone marrow on the out-of-phase and in-phase images.
This signal intensity ratio was calculated as the mean signalintensity on out-of-phase images divided by the mean signal
intensity on the in-phase images. By using this formula which
was also used in other studies, we calculated in our study a
mean signal intensity ratio of 1.22 (range 1.10–1.31) for the
neoplastic group and 0.71 (range 0.59–1.30) for the benign
group (P< 0.05), and these results were in concordance with
Ogura et al. (20).
Using ROC analysis, we identiﬁed in our study a SIR cutoff
value of 0.94 between benign and malignant vertebral com-
pression fractures, which is higher than that reported by Erly
et al. (21) namely 0.8, but less than the cutoff value of one
reported by Ogura et al. (20). In our study a SIR cutoff value
of 0.94 resulted in 93% sensitivity, 72% speciﬁcity and 88%
accuracy in the discrimination between benign and malignant
vertebral compression fractures. These results were in concor-
dance with Zidan et al. (17) who reported 93% sensitivity and
82% speciﬁcity, and with Erly et al. (21) who reported 95%
sensitivity and 89% speciﬁcity.
These results however, differ from the results of
another study done by Geith et al. (22) in which 69.2% of
Fig. 11 A 59-year-old man with known left tibial osteosarcoma underwent above knee amputation presented with back pain and fever.
(a) Sagittal precontrast T1-weighted spin-echo image shows diffuse low signal intensity of L4 and L5 vertebrae associated with
prevertebral and epidural soft tissue mass lesion extending to posterior elements of the vertebrae and adjacent back muscles reaching the
subcutaneous fat. (b) Sagittal T2-weighted spin-echo image and (c) sagittal STIR show corresponding high signal intensity and bright
signal of L4/5 disk. (d) DW image shows diffusion restriction of L4 and L5 vertebrae and intervening disk as well as the prevertebral and
back muscles component. (e) ADC map shows a high apparent diffusion coefﬁcient (ADC) value of 1.452  103 mm2/s, which conﬁrms
the inﬂammatory/infectious nature of the lesion. (f) In-phase and (g) out-of-phase gradient-echo MR images show corresponding brighter
signal on out-of-phase image compared with in-phase (f) with calculated mean SIR = 0.8. (h) Sagittal contrast-enhanced T1-weighted fat-
suppressed MR image shows corresponding avid enhancement. MR diagnosis, L4/5 spondylodiscitis with prevertebral and back muscles
abscess. Pathology conﬁrmed pyogenic spondylodiscitis with 6 month follow-up revealed resolution and reconstitution of normal marrow
signal.
Discrimination between benign and malignant in vertebral marrow lesions 567all osteoporotic fractures showed a hyperintense signal on
opposed phase images (false-positive). They did not ﬁnd a
signiﬁcant difference in SI on the opposed-phase images of
benign and malignant vertebral lesions, and were able to reach
a sensitivity of only 50%, and a speciﬁcity of 88.5%. In an
attempt to explain their results, they noted that this ﬁnding
could be attributable to the fact that an equal amount of
50% fat and 50% water is not always present in benign lesions
because of edema, resulting in more or less of a hyperintense
signal on the opposed-phase images. Some overlap in the
signal intensity ratio between the malignant and the benign
marrow lesions, also occurred in our study, as benign lesions
in 4 patients had a ratio greater than 0.94 and a single malig-
nant lesion in one patient had a value less than 0.94.The false positive results in CSI were seen in 4 patients, 2 of
them had Pott’s disease and 2 had pyogenic spondylodiscitis
with massive bone marrow edema that did not show signal
dropout on out-of-phase sequence due to abundant water;
however, the edema did appear clearly on the T2WI and STIR
sequences.
In our patient population 15 out of 16 malignant vertebral
compressions did not show a signal dropout on out-of-phase
images. This was in agreement with Swartz and Robert (23)
who reported false negative pitfalls due to dense sclerotic or
fat containing metastases.
Our results showed that the sensitivity, speciﬁcity and
accuracy for diffusion weighted imaging were 94%, 92%,
and 93% respectively, which were almost comparable to those
Fig. 12 A 75-year-old man with prostate cancer received targeted radiotherapy. The patient presented with generalized bony aches and
bilateral sciatica. (a) Sagittal precontrast T1-weighted spin-echo image and (b) Sagittal T2-weighted spin-echo image show focal low signal
intensity marrow deposits involving D12, L2, L3 and L4 vertebrae as well as diffuse inﬁltration of D11 and L1 vertebrae. Compression
collapse of L1 with retropulsion and thecal sac compression is noted. L5 and sacral vertebral bodies show fat marrow replacement due to
radiation therapy targeting the prostate. (c) Sagittal STIR shows mild high signal intensity of the marrow lesions. (d) DW image shows
focal and diffuse hyperintense signal corresponding to the low signal intensity lesions on T1WI. (e) ADC map shows average apparent
diffusion coefﬁcient (ADC) value of 0.624  103 mm2/s. (f) In-phase and (g) out-of-phase gradient-echo MR images show vertebral
marrow lesions appearing brighter on out-of-phase image compared with in-phase (f) with calculated mean SIR = 1.4. The fatty
inﬁltrated L5 and sacral vertebrae remain hyperintense on both in- and out-of-phase images. Note that Modic type 2 degenerative marrow
changes at L2 and L3 vertebral end plates have similar signal intensity as subcutaneous fat and do not dropout on out-of-phase imaging
(arrow) (h) Sagittal contrast-enhanced T1-weighted fat-suppressed MR image shows a mild enhancement of the focal and inﬁltrative
marrow lesions. MR diagnosis, Multi-level focal and inﬁltrative marrow deposits as detailed above. Six month follow-up conﬁrmed
progressive deterioration of the vertebral lesions.
568 M.Y. Tadros, A.L. Loukacalculated for chemical shift imaging, where sensitivity of 93%,
speciﬁcity of 72% and accuracy of 93% were reported.
In conclusion, we suggest that quantitative diffusion
weighted imaging and chemical shift MR imaging could be a
valuable addition to standard MR imaging techniques and
represent a rapid problem solving tool in differentiating benign
from malignant vertebral marrow lesions, especially in patients
with known primary malignancies.
Conﬂict of interest
We have no conﬂict of interest to declare.References
(1) Jung HS, Jee WH, McCauley TR, Ha KY, Choi KH. Discrim-
ination of metastatic from acute osteoporotic compression spinal
fractures with MR imaging. Radiographics 2003;23:179–87.
(2) Zajack DC, Morrison WB, Schweitzer ME, Parellada JA, Carrino
JA. Benign and malignant processes: normal values and differ-
entiation with chemical shift MR imaging in vertebral marrow.
Radiology 2005;237:590–6.
(3) Mubarak F, Akhtar W. Acute vertebral compression fracture:
Differentiation of malignant and benign causes by diffusion
weighted magnetic resonance imaging. J Pak Med Assoc 2011;61
(6).
Discrimination between benign and malignant in vertebral marrow lesions 569(4) Khoo MM, Tyler PA, Saifuddin A, Padhani AR. Diffusion
weighted imaging (DWI) in musculoskeletal MRI: a critical
review. Skeletal Radiol 2011;40:665–81.
(5) Zhao J, Krug R, Xu D, et al. MRI of the Spine: image quality and
normal-neoplastic bone marrow contrast at 3 T versus 1.5 T. AJR
2009;192:873–80.
(6) Zidan DZ, El ghazaly HA. Can unenhanced multipara metric
MRI substitute gadolinium-enhanced MRI in the characteriza-
tion of vertebral marrow inﬁltrative lesions? Egypt J Radiol Nucl
Med 2014.
(7) Grifﬁth JF, Yeung DK, Antonio GE, et al. Vertebral bone
mineral density, marrow perfusion, and fat content in healthy
men and men with osteoporosis: dynamic contrast-enhanced MR
imaging and MR spectroscopy. Radiology 2005;236:945–51.
(8) Beltran J, Shankman S. MR imaging of bone lesions of the ankle
and foot. Magn Reson Imaging Clin N Am 2001;9:553–66.
(9) Schmid MR, Hodler J, Vienne P, Binkert CA, Zanetti M. Bone
marrow abnormalities of foot and ankle: STIR imaging versus
T1-weighted contrast-enhanced fat-saturated spin-echo MR
imaging. Radiology 2002;224:463–9.
(10) Koh D, Blackledge M, Padhani A, et al. Whole-body diffusion
weighted MRI: tips, tricks, and pitfalls. AJR 2012;199:252–62;
Ballon D, Watts R, Dyke JP, et al. Imaging therapeutic response
in human bone marrow using rapid whole-body MRI. Magn
Reson Med 2004;52:1234–8.
(11) Ballon D, Watts R, Dyke JP, et al. Imaging therapeutic response
in human bone marrow using rapid whole-body MRI. Magn
Reson Med 2004;52:1234–8.
(12) Padhani A, Koh DM, Collins D. Whole-body diffusion-weighted
MR imaging in cancer: current status and research directions.
Radiology 2011;261:3.
(13) Hillengass J, Bauerle T, Bartl R, et al. Diffusion-weighted
imaging for non-invasive and quantitative monitoring of bone
marrow inﬁltration in patients with monoclonal plasma cell
disease: a comparative study with histology. Br J Haematol
2011;153(6):721–8.(14) Wonglaksanapimon S, Chawalparit O, Khumpunnip S, Tri-
trakarn SO, Chiewvit P, Charnchaowanish P. Vertebral body
compression fracture: discriminating benign from malignant
causes by diffusion-weighted MR imaging and apparent diffusion
coefﬁcient value. J Med Assoc Thai 2012;95(1):81–7.
(15) Sung JK, Jee WH, Jung JY, Choi M, Lee SY, Kim YH, et al.
Differentiation of acute osteoporotic and malignant compression
fractures of the spine: use of additive qualitative and quantitative
axial diffusion-weighted MR imaging to conventional MR
imaging at 3.0 T. Radiology 2014;271(2):488–98.
(16) Gokalp G, Mutlu FS, Yazici Z, Yildrim N. Evaluation of
vertebral bone marrow fat content by chemical-shift MRI in
osteoporosis. Skeletal Radiol 2011;40:577–85.
(17) Zidan DZ, Habib LA, Chalabi NA. Quantitative chemical-shift
MR imaging cutoff value: benign versus – The Egyptian. J Radiol
Nucl Med 2014;45:779–86.
(18) Roberts C, Daffner R, Weissman B, et al. ACR appropriateness
criteria on metastatic bone disease. J Am Coll Radiol
2010;7:400–9.
(19) Moulopoulos LA. Effect of treatment on normal tissue: bone
marrow. In: Husband JE, Reznek RH, editors. Imaging in
oncology. London: Taylor & Francis; 2004. p. 1277–87.
(20) Ogura A, Hayakawa K, Maeda F, et al. Differential diagnosis of
vertebral compression fracture using in-phase/opposed-phase and
short TI inversion recovery imaging. Acta Radiol 2012;53:450–5.
(21) Erly WK, Oh ES, Outwater EK. The utility of in-phase/opposed-
phase imaging in differentiating malignancy from acute benign
compression fractures of the spine. AJNR 2006;27(6):1183–8.
(22) Geith T, Schmidt G, Biffar A, et al. Comparison of qualitative
and quantitative evaluation of diffusion-weighted MRI and
chemical-shift imaging in the differentiation of benign and
malignant vertebral body fractures. AJR 2012;199:1083–92.
(23) Swartz PG, Roberts CC. Radiological reasoning: bone marrow
changes on MRI. AJR 2009;193:S1–4.
